References

  1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4):1333-1342. PubMed | Google Scholar

  2. Madhava V, Burges C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002; 2(5):293-302. PubMed | Google Scholar

  3. Ntagirabiri R, Baransaka E, Ndayiragije A, Niyongabo T. Prevalence of hepatitis C virus in Burundi: a nationwide survey. J Afr Hépatol Gastroentérol. 2014;8(1):25-28. PubMed | Google Scholar

  4. Kuiken C, Simmonds P. Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol. 2009;510:33-53. PubMed | Google Scholar

  5. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):41-46. PubMed | Google Scholar

  6. Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, Bailly F, Castera L, De Ledinghen V, Marcellin P, Poupon R, Bourlière M, Zarski J P, Roudot-Thoraval F. The Observational VHC4 Study Group: Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat. 2007;14(7):460-467. PubMed | Google Scholar

  7. Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, Bouviers-Alias M, Trimoulet P, Chaix M L, Hézode C, Foucher J, Fontaine H, Roque-Afonso A-M, Gassin M, Schvoerer E, Gaudy C, Roche B, Doffoël M, D'Alteroche L, Vallet S, Baazia Y, Pozzetto B, Thibault V, Nousbaum J-B, Roulot D, Coppere H, Poinard T, Payan C, Izopet J. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. J Med Virol. 2009; 81(12): 2029-2035. PubMed | Google Scholar

  8. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antiviral Ther. 2005;10(1):1-11. PubMed | Google Scholar

  9. Nguyen MH, Keeffe EB. Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. Clin Gastroenterol Hepatol. 2005;3(10 Suppl 2):S97-S101. PubMed | Google Scholar

  10. Abdel-Aziz F, Habib M, Mohamed M K, Abdel-Hamid M, Gamil F, Madkour S, Mikhail N N, Thomas D, Fix A D, Strickland G T, Anwar W, Sallam I. Hepatitis C virus (HCV) infection in a community in the nile delta: Population description and HCV prevalence. Hepatology. 2000; 32 (1):111-115. PubMed | Google Scholar

  11. Pasquier C, Njouom R, Ayouba A, Dubois M, Sartre M T, Vessière A, Timba I, Thonnon J, Izopet J, Nerrienet E. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol. 2005;77(3):390-398. PubMed | Google Scholar

  12. Njouom R , Caron M, Besson G, Ndong-Atome G R, Makuwa M, Pouillot R Nkoghe D, Leroy E, Kazanji M. Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, Central Africa. PLoS ONE. August 2012; 7(8):e42002. PubMed | Google Scholar

  13. Kamal S M, Nasser I A. Hepatitis C Genotype 4: What we know and what we don’t yet know. Hepatology. 2008; 47(4):1371-1383. PubMed | Google Scholar

  14. Ndjomou J, Pybus OG, Matz B. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J Gen Virol. 2003;84(9):2333-2341. PubMed | Google Scholar

  15. Tanaka Y, Agha S, Saudy N, Kurbanov F, Orito E, Kato T, Abo-Zeid M, Khalaf M, Miyakawa Y, Mizokami M. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol. 2004;58 (2):191-195. PubMed | Google Scholar

  16. Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, Amin G, Capocaccia L, Callea L, Rapicetta M, Badr G, Rocchi G. Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections. J Hepatol. 1997;26(2):236-243. PubMed | Google Scholar

  17. Rouabhia S, Sadelaoud M, Chaabna-Mokrane K, Toumi W, Abenavoli L. Hepatitis C virus genotypes in north eastern Algeria: A retrospective study. World J Hepatol. 2013; 5(7): 393-39. PubMed | Google Scholar

  18. Alashek W, Altagdi M. Risk factors and genotypes of hepatitis C virus infection in libyan patients. Libyan J Med. 2008;3(4):162-165. PubMed | Google Scholar

  19. Al Ashgar HI, Khan MQ, Al-Ahdal M, Al Thawadi S, Helmy AS, Al Qahtani A, Sanai FM. Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia. Saudi J Gastroenterol. 2013;19(1):28-33. PubMed | Google Scholar

  20. Simmonds P. Genetic diversity and evolution of hepatitis C virus—15 years on. J Gen Virol. 2004;85(11):3173-3188. PubMed | Google Scholar

  21. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. The origin of hepatitis C virus genotypes. J Gen Virol. 1997;78(2):321-328. PubMed | Google Scholar

  22. Xu L-Z, Larzul D, Delaporte E, Bréchot C, Kremsdorf D. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J Gen Virol. 1994;75(9):2393-2398. PubMed | Google Scholar

  23. Njouom R, Nerrienet E, Dubois M, Lachenal G, Rousset D, Vessière A, Ayouba A, Pasquier C, Pouillot R. The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. Infect Genet Evol. 2007;7(3):361-367. PubMed | Google Scholar

  24. Pybus O, Drummond A, Nakano T, Robertson BH, Rambaut A. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol. 2003;20(3):381-387. PubMed | Google Scholar

  25. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis. 2000;182(3):698-707. PubMed | Google Scholar